MYC has been reported to positively regulate PD-L1 expression in a variety of cancers, including esophageal squamous cell carcinoma [80], NSCLC [79], and lymphoma [75], with evidence indicating that MYC directly regulates the expression of PD-L1 at the transcriptional level [108]. Here, MYC is linked to cancer.